Impact ledger
Alexion Pharmaceuticals, Inc. (AstraZeneca) (ALXN)
2 events mapped to this ticker since 2026-06-12.
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-06-29 | Event | Indirect sentiment impact on companies with established or developing therapies for rare immunological conditions, as a reminder of clinical trial risks. | watch | 1-3m | 0.20 |
| 2026-06-12 | Event | Increased competitive pressure in the hereditary angioedema (HAE) market. Alexion has established HAE treatments (e.g., Soliris, Ultomiris). The entry of a new oral on-demand treatment like sebetralstat, backed by Chiesi, could impact Alexion's market share or pricing power in the HAE segment. | watch | 3-12m | 0.40 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for ALXN, start a trial or view the ALXN entity page.